Status:
COMPLETED
Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD
Lead Sponsor:
Novartis
Conditions:
ADHD
Eligibility:
All Genders
6-12 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ...
Eligibility Criteria
Inclusion
- DSM-IV diagnosis of ADHD
- Males and females aged 6-12
Exclusion
- Inability of understand or follow instructions
- Is pregnant
- Diagnosis of tic disorder
- History of seizure disorder
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
End Date :
August 1 2005
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00141063
Start Date
June 1 2005
End Date
August 1 2005
Last Update
December 21 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Psychiatry & Behavioral Medicine
Las Vegas, Nevada, United States, 89128